Prognosis and anticoagulant pro-phylaxis after coronary occlusion (Q79078335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13774138%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Prognosis and anticoagulant pro-phylaxis after coronary occlusion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13774138%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

1 reference

J MCMICHAEL

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13774138%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

E H PARRY

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13774138%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

publication date

1 November 1960

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13774138%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13774138%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13774138%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

7158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13774138%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

991-998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13774138%20AND%20SRC:MED&resulttype=core&format=json

Thromboplastic and fibrinolytic activity of the human aorta

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Initial myocardial infarction among 503 veterans: five-year survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

The international study of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Prognosis of angina pectoris; observations in 6,882 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Myocardial infarction in a haemophiliac

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Survival of diabetic patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

The influence of anticoagulant therapy on the incidence of thromboembolism, hemorrhage and cardiac rupture in acute myocardial infarction; correlation of clinical and autopsy data in 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

The long-term prognosis following myocardial infarction, and some factors which affect it

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Recurrent myocardial infarction after cessation of anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Long-term anticoagulant therapy in coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Anticoagulant therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Experiences with long-term anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

An evaluation of anticoagulant therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Prognostic factors in myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

The problem of interpretation of results obtained by long-term anticoagulant treatment in myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Prognosis of Patients Surviving First Clinically Diagnosed Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Survival after recent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Survival rates after acute myocardial infarction with long-term anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Some implications of mortality statistics relating to coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

The prevention of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Anticoagulant therapy in acute cerebrovascular accidents. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Coronary heart disease in medical practitioners

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Long-term treatment with dicumarol in myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Long-term dicumarol therapy to prevent recurrent coronary artery thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

An attempt to forestall acute coronary thrombosis; preliminary note on the continuous use of dicumarol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Long-term anticoagulant therapy in coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Life expectancy in angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

The accuracy of diagnosis of myocardial infarction; a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

A completed twenty-five-year follow-up study of 200 patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Chances for survival in acute myocardial infarction: survey of the acute phase in 1,318 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Prognosis of angina pectoris and coronary occlusion; follow-up of 1,700 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

The Fate of the Claudicator

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Atherosclerosis in a haemophiliac

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

An evaluation of the effect of continuous long-term anticoagulant therapy on the prognosis of myocardial infarction: a report of 82 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Phenylindandione in therapy of coronary artery disease; study of its long-term use in ambulatory patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Long-term anticoagulant therapy of the ambulatory patient following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Long-term anticoagulant therapy for coronary thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Long-term anticoagulant therapy; further experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

The effect of permanent anticoagulant therapy on symptoms and mortality in angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Ten-year prognosis of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Five-year follow-up study of men who returned to work after a myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Prognostic features of acute myocardial infarction in men. A one-year study at the Los Angeles County Hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Report of the Committee for the Evaluation of Anticoagulants in the Treatment of Coronary Thrombosis with Myocardial Infarction; a progress report on the statistical analysis of the first 800 cases studied by this committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021

Long-term anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2860%2992077-8

7 January 2021